Healthcare Brief Comoros: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Brief Comoros.

Press releases published on October 28, 2026

8 hours ago

Propanc Biopharma Advances Clinical Development Preparation for PRP Phase 1b First-In-Human Study in Up to 50 Advanced Cancer Patients

Indeterminate GlobeNewswire

8 hours ago

60 Degrees Pharmaceuticals Announces Partnership with The University of Southern Mississippi to Evaluate Castanospermine in Nonclinical Models of Alpha-Gal Syndrome

Indeterminate GlobeNewswire

8 hours ago

MaxCyte to Participate in Three Upcoming Investor Conferences

Indeterminate GlobeNewswire

8 hours ago

ProQR to Present Clinical and Preclinical Progress from AX-0810 and AX-0811 at Upcoming Conferences

Indeterminate GlobeNewswire

8 hours ago

BrainsWay to Report Third Quarter 2026 Financial Results on November 10, 2026

Indeterminate GlobeNewswire

8 hours ago

Neumarker Enter Collaboration to Advance Precision Medicine in Depression

Indeterminate GlobeNewswire

8 hours ago

TCG Labs Soleil Highlights Portfolio Momentum with Three Programs Entering First-in-Human Clinical Trials Across Oncology and Cardiovascular Disease

Indeterminate GlobeNewswire

8 hours ago

Noom Study Finds Members Further Along in Its GLP-1Rx Program Report Higher “Flourishing” and “Quality of Life”

Indeterminate GlobeNewswire

8 hours ago

Annexon to Host Virtual Investor Event on November 3, 2026: Vonaprument for the Treatment of Geographic Atrophy - Highlighting Key Aspects of Phase 3 ARCHER II Trial

Indeterminate GlobeNewswire

8 hours ago

electroCore, Inc. Submits 510(k) Premarket Notification to FDA Seeking Clearance of Quell® for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy (CIPN)

Indeterminate GlobeNewswire

8 hours ago

Sofwave to Participate in Upcoming November Investor Conferences

Indeterminate GlobeNewswire

8 hours ago

Curabotics Enters National Contract with Capstone Health Alliance, Bringing Robotics and Automation to Hundreds of Hospitals

Indeterminate GlobeNewswire

8 hours ago

Geron Corporation Provides Update on Phase 3 IMpactMF Clinical Trial of Imetelstat in Relapsed/Refractory Myelofibrosis

Indeterminate GlobeNewswire

8 hours ago

Humacyte Strengthens Intellectual Property Portfolio with Issuance of New U.S. Patent Covering Symvess and Other Bioengineered Tissues

Indeterminate GlobeNewswire

8 hours ago

Newron Pharmaceuticals to Participate in November Investor Conferences

Indeterminate GlobeNewswire

8 hours ago

Scipher Medicine Launches PrismTcell™, the Next Molecular Treatment Response Signature, for Abatacept in Rheumatoid Arthritis

Indeterminate GlobeNewswire

8 hours ago

INmune Bio, Inc. Announces Pricing of $4.50 Million Registered Direct Offering and Concurrent Private Placement

Indeterminate GlobeNewswire

8 hours ago

UroGen’s Final Results from Olympus Five-Year Follow-Up Study Reinforces Durable Response with JELMYTO in Patients with Low-Grade Upper Tract Urothelial Cancer

Indeterminate GlobeNewswire

8 hours ago

ORYZON to participate in upcoming events in November

Indeterminate GlobeNewswire

8 hours ago

Filana Therapeutics Announces Publication in Cells of Promising Preclinical Findings for Simufilam in TSC2-Deficient Cells

Indeterminate GlobeNewswire